SCHOTT Pharma AG & Co. KGaA Cash Flow Conversion Efficiency

Latest as of September 2024: 0.096x

SCHOTT Pharma AG & Co. KGaA cash flow conversion efficiency. Based on the latest financial reports, SCHOTT Pharma AG & Co. KGaA (1SXP) has a cash flow conversion efficiency ratio of 0.096x as of September 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€75.97 Million ≈ $88.82 Million USD) by net assets (€792.27 Million ≈ $926.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of SCHOTT Pharma AG & Co. KGaA (2020–2024)

Cash flow conversion efficiency of SCHOTT Pharma AG & Co. KGaA from 2020 to 2024. This chart illustrates how SCHOTT Pharma AG & Co. KGaA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SCHOTT Pharma AG & Co. KGaA (1SXP) share price today for real-time trading data and today's change.

SCHOTT Pharma AG & Co. KGaA Cash Flow Conversion Ratio Explained

SCHOTT Pharma AG & Co. KGaA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

SCHOTT Pharma AG & Co. KGaA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SCHOTT Pharma AG & Co. KGaA ranked by their cash flow conversion efficiency. Also see SCHOTT Pharma AG & Co. KGaA market cap and net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Henan Huanghe Whirlwind Co Ltd SHG:600172	-0.034x
Liberty Energy Inc. NYSE:LBRT	0.068x
Zhejiang Provincial New Energy Investment Group Co Ltd SHG:600032	0.139x
Chung-Hsin Electric & Machinery Mfg Corp TW:1513	0.031x
CECEP Solar Energy Co Ltd SHE:000591	0.112x
Charoen Pokphand Indonesia TBK PT JK:CPIN	0.059x
Coface SA PA:COFA	0.021x
Top Choice Medical Investment Co Inc SHG:600763	0.069x

Annual Cash Flow Conversion Efficiency for SCHOTT Pharma AG & Co. KGaA (2020–2024)

The table below shows the annual cash flow conversion efficiency of SCHOTT Pharma AG & Co. KGaA from 2020 to 2024. Review 1SXP cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-06-30	€792.27 Million ≈ $926.25 Million	€225.33 Million ≈ $263.43 Million	0.284x	+8.37%
2023-06-30	€692.18 Million ≈ $809.23 Million	€181.65 Million ≈ $212.37 Million	0.262x	+2.17%
2022-06-30	€709.04 Million ≈ $828.95 Million	€182.12 Million ≈ $212.92 Million	0.257x	-18.52%
2021-06-30	€419.42 Million ≈ $490.34 Million	€132.21 Million ≈ $154.57 Million	0.315x	-4.69%
2020-06-30	€315.66 Million ≈ $369.04 Million	€104.40 Million ≈ $122.05 Million	0.331x	--

About SCHOTT Pharma AG & Co. KGaA

XETRA:1SXP Germany Medical Instruments & Supplies

Market Cap

$4.41 Billion

€3.77 Billion EUR

Market Cap Rank

#5395 Global

#871 in Germany

Share Price

€25.05

Change (1 day)

+0.20%

52-Week Range

€12.96 - €26.00

All Time High

€41.20